POINT 303

Hazard statements (CLP)

H317, H334, H351

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

Hazard labelling pursuant to EC Regulation 1272/2008 (CLP) and subsequent amendments and supplements. Classification of the substance or mixture

Signal word

Danger 1 | 12

Hazard statements

H351 Suspected of causing cancer. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction.

Precautionary statements

P261 Avoid breathing dust / fume / gas / mist / vapours / spray. P280 Wear protective gloves/ protective clothing / eye protection / face protection. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER / doctor. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P102 Keep out of reach of children. P284 [In case of inadequate ventilation] wear respiratory protection. P302+P352 IF ON SKIN: Wash with plenty of water. P333+P313 If skin irritation or rash occurs: Get medical advice / attention. P501 Dispose of contents and container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation

Contains

4,4'-methylenediphenyl diisocyanate, Diphenylmethane-4,4'-diisocyanate Persons already sensitised to diisocyanates may develop allergic reactions when using this product. Persons suffering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. This product should not be used under conditions of poor ventilation unless a protective mask with an appropriate gas filter (i.e. type A1 according to standard EN 14387) is used. As from 24 August 2023 adequate training is required before industrial or professional use.

2.3 Other hazards

On the basis of available data, the product does not contain any PBT or vPvB in percentage than 0,1%. The product does not contain substances with endocrine disrupting properties in concentration 0.1%.

2.1 Classification of the substance or mixture

The product is classified as hazardous pursuant to the provisions set forth in (EC) Regulation 1272/2008 (CLP) (and subsequent amendments and supplements). The product thus requires a safety datasheet that complies with the provisions of (EU) Regulation 2020/878. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. Hazard classification and indication: Carcinogenicity, category 2 H351 Suspected of causing cancer. Respiratory sensitization, category 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitization, category 1 H317 May cause an allergic skin reaction.